S100A2 Antikörper (full length)

Produktnummer ABIN7878955

Der Maus Monoklonal anti-S100A2 Antikörper (Klon S100A2-6925) (ABIN7878955) detektiert spezifisch S100A2 in IHC (p). Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für S100A2 Antikörper (full length) (ABIN7878955)

Target: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser S100A2 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon: S100A2-6925

Produktdetails anti-S100A2 Antikörper

Bindungsspezifität: full length

Verwendungszweck: S100A2 Antibody / S100 Calcium Binding Protein A2

Aufreinigung: Protein A/G affinity

Immunogen: Recombinant full-length human protein was used as the immunogen for the S100A2 antibody.

Isotyp: IgG2b, kappa

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the S100A2 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the S100A2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu S100A2

Target: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Andere Bezeichnung: S100A2

Hintergrund: S100A2 belongs to the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100A2 may function as a modulator against excess calcium accumulation in normal human mammary epithelial cells and also have a role in suppressing tumor cell growth. This protein may have a tumor suppressor function. Chromosomal rearrangements and altered expression of this gene have been implicated in breast cancer. Cytoplasmic overexpression may also be of prognostic significance when observed in oral cancer patients, and the S100A2 has also been identified as significantly down regulated in gastric cancer.

UniProt: P29034

Pathways: S100 Proteine